Trial reportArchives of orthopaedic and trauma surgery2026
Combined iPACK and adductor canal block versus two-level erector spinae plane block in elderly patients undergoing total knee arthroplasty: a randomized, triple-blinded clinical trial.
Trial report in Archives of orthopaedic and trauma surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06470542 (Two-level Erector Spinae vs iPack With ACB Plane Block in Total Knee Arthroplasty), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Two-level Erector Spinae vs iPack With ACB Plane Block in Total Knee Arthroplasty
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEffective postoperative pain management after total knee arthroplasty (TKA) in elderly patients is challenging because of their increased susceptibility to opioid-related adverse events. Motor-sparing regional anesthesia techniques such as the adductor canal block (ACB), the interspace between the popliteal artery and the posterior capsule of the knee (iPACK) block, and the erector spinae plane block (ESPB) may improve analgesia while preserving quadriceps strength and modulating the systemic stress response.
methodsIn this single-center, prospective, randomized, triple-blinded trial, 60 patients aged 65–100 years undergoing primary TKA under spinal anesthesia were allocated to receive either combined iPACK + ACB (20 mL of 0.2% ropivacaine for each block) or a two-level lumbar–sacral ESPB at L1 and S1 (20 mL of 0.2% ropivacaine at each level). The primary outcome was total opioid consumption within 48 h, expressed in morphine milligram equivalents (MME). Secondary outcomes included time to first rescue opioid, Numerical Rating Scale (NRS) pain scores, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and quadriceps strength (Medical Research Council scale).
resultsCompared with two-level ESPB, iPACK + ACB significantly reduced total opioid consumption (9.7 ± 5.4 vs 12.9 ± 6.9 mg MME; p = 0.0348) and prolonged the time to first rescue opioid (9.3 ± 4.3 vs 8.5 ± 3.4 h; p = 0.0263). NRS scores were lower at 8 h (2.6 ± 0.8 vs 3.3 ± 0.7; p = 0.0037), with no relevant differences thereafter. NLR at 24 h was significantly lower with iPACK + ACB (2.20 ± 0.41 vs 2.61 ± 0.45; p = 0.0015), whereas PLR did not differ. Quadriceps strength remained preserved (MRC 5) in both groups.
conclusionIn elderly patients with TKA, combined iPACK + ACB provides more effective, opioid-sparing analgesia and attenuates the early inflammatory response compared with two-level lumbar–sacral ESPB, without compromising quadriceps motor function. Trial registration: ClinicalTrials.gov Identifier: NCT06470542.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.